Vertex Pharmaceuticals Inc (VRTX) support and resistance · P/E 30, rev $12.00B
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
This page maps Vertex Pharmaceuticals Inc (VRTX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
VRTX currently screens at market cap $106.87B and trailing P/E 29.7. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VRTX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VRTX quote page for the session range and the stock page for the full model.
Not investment advice.